Literature DB >> 16466031

Adherence to anti-tuberculosis chemoprophylaxis and treatment in children.

S van Zyl1, B J Marais, A C Hesseling, R P Gie, N Beyers, H S Schaaf.   

Abstract

SETTING: Limited data exist on adherence to anti-tuberculosis treatment and chemoprophylaxis in children in high-burden settings.
OBJECTIVE: To determine the adherence to anti-tuberculosis chemoprophylaxis and treatment in children evaluated as household contacts of adult pulmonary tuberculosis (PTB) cases.
METHODS: A retrospective study, conducted from January 1996 to September 2003, in suburban Cape Town, South Africa, with a high TB incidence. A folder search was done on all children <5 years of age identified as household contacts of adult PTB cases between 1996 and 2003. Data on screening for TB and adherence to prescribed therapy in child contacts were analysed.
RESULTS: Three hundred and sixty-one contact episodes with 243 adult PTB cases were identified in 335 children. The median age was 25 months. Adherence to anti-tuberculosis treatment was significantly better than adherence to chemoprophylaxis (82.6% vs. 44.2%; OR 6.83; 95%CI 3.6-12.96). Adherence to a 3-month chemoprophylaxis regimen of isoniazid and rifampicin (3HR) was significantly better than adherence to a 6-month chemoprophylaxis regimen of isoniazid only (69.6% vs. 27.6%; OR 4.97; 95%CI 2.40-10.36).
CONCLUSIONS: Although adherence to treatment was good, adherence to unsupervised chemoprophylaxis was poor. We recommend that shorter chemoprophylaxis regimens such as 3HR should be considered to improve adherence, but further studies are required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466031

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  41 in total

1.  A relook at preventive therapy for tuberculosis in children.

Authors:  Varinder Singh; Soumya Patra
Journal:  Indian J Pediatr       Date:  2010-10-27       Impact factor: 1.967

2.  Adherence to isoniazid preventive chemotherapy: a prospective community based study.

Authors:  B J Marais; Susan van Zyl; H S Schaaf; M van Aardt; R P Gie; N Beyers
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

3.  Tuberculosis Treatment Outcomes Among Children in Rural Southern Mozambique: A 12-year Retrospective Study.

Authors:  Troy D Moon; Edy Nacarapa; M Elisa Verdu; Salésio Macuácua; Didier Mugabe; Wu Gong; James G Carlucci; Jose M Ramos; Emilio Valverde
Journal:  Pediatr Infect Dis J       Date:  2019-10       Impact factor: 2.129

4.  Routine programmatic delivery of isoniazid preventive therapy to children in Cape Town, South Africa.

Authors:  M Osman; A C Hesseling; N Beyers; D A Enarson; I D Rusen; C Lombard; S S van Wyk
Journal:  Public Health Action       Date:  2013-09-21

5.  It's hard work, but it's worth it: the task of keeping children adherent to isoniazid preventive therapy.

Authors:  D Skinner; A C Hesseling; C Francis; A M Mandalakas
Journal:  Public Health Action       Date:  2013-09-21

Review 6.  Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

7.  Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia.

Authors:  Merrin E Rutherford; Rovina Ruslami; Melissa Anselmo; Bachti Alisjahbana; Neti Yulianti; Hedy Sampurno; Reinout van Crevel; Philip C Hill
Journal:  Bull World Health Organ       Date:  2013-09-10       Impact factor: 9.408

8.  Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.

Authors:  Larissa Otero; Tullia Battaglioli; Julia Ríos; Zayda De la Torre; Nayda Trocones; Cielo Ordoñez; Carlos Seas; Patrick Van der Stuyft
Journal:  Trop Med Int Health       Date:  2019-12-12       Impact factor: 2.622

9.  Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosis.

Authors:  Marian Loveday; Babu Sunkari; Ben J Marais; Iqbal Master; James C M Brust
Journal:  Arch Dis Child       Date:  2016-04-04       Impact factor: 3.791

10.  Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules.

Authors:  Stanzi M le Roux; Mark F Cotton; Jonathan E Golub; David M le Roux; Lesley Workman; Heather J Zar
Journal:  BMC Med       Date:  2009-11-03       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.